The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor
Lu Sun,1 Xiaorong Sun,2 Yuhui Li,3 Ligang Xing4 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 2PET/CT Center, Department of Radiology, 3Department of Pathology, 4Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shand...
Main Authors: | Sun L, Sun XR, Li YH, Xing LG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-07-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/the-role-of-18f-fdg-petct-imaging-in-patient-with-malignant-pecoma-tre-peer-reviewed-article-OTT |
Similar Items
-
Perivascular Epithelioid Cell Tumors (PEComas) Refractory to mTOR Inhibitors
by: San-Chi Chen, et al.
Published: (2014-09-01) -
Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas
by: Maria-Iulia Larg, et al.
Published: (2019-08-01) -
18F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
by: Smeeta Gajendra, et al.
Published: (2016-01-01) -
The Role of 18F-FDG PET/CT in the Diagnosis of Malignant Pleural Mesothelioma
by: İhsan Kaplan
Published: (2021-06-01) -
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature
by: Aikaterini Liapi, et al.
Published: (2021-03-01)